Position in BIIB
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$177,385
+$27,055 QoQ
Shares Held
821
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#769
of 1,031 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PIN OAK INVESTMENT ADVISORS INC holds $4,178,060 across 13 Drug Manufacturers - General names. BIIB ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,063 | $1,793,790 | |
| 2 | ABBV |
AbbVie Inc.
|
2,819 | $709,373 | |
| 3 | PFE |
Pfizer Inc
|
24,253 | $584,012 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,079 | $395,651 | |
| 5 | LLY |
ELI LILLY & Co
|
165 | $197,905 | |
| 6 | NVS |
Novartis AG
|
1,253 | $196,370 | |
| 7 | BIIB |
Biogen Inc.
This page
|
821 | $177,385 | |
| 8 | AMGN |
Amgen Inc
|
279 | $101,031 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $177,385 | 821 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $150,330 | 820 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $165 | 820 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $114,865 | 820 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $102,983 | 820 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $112,208 | 820 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $159 | 820 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $158,948 | 820 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $190,092 | 820 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $176,816 | 820 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $212,191 | 820 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $210,748 | 820 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $233,577 | 820 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $227,984 | 820 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $227,074 | 820 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $218,940 | 820 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $167,230 | 820 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $172,692 | 820 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $196,734 | 820 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $232,051 | 820 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $283,941 | 820 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $229,395 | 820 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $200,785 | 820 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $232,617 | 820 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $219,391 | 820 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $259,431 | 820 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||